Abstract 3365: MAP3K10 mutation as a biomarker for predicting response to chemotherapy in gastric cancer patients
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-3365
Abstract: Gastric cancer is one of most common malignant tumors. Although chemotherapy can improve the survival of gastric cancer, the benefit is limited because most cancer cells eventually become irresponsive to chemotherapeutic drugs. To investigate mechanism… read more here.
Keywords: gastric cancer; map3k10; cancer; biomarker predicting ... See more keywords